Mexico vs Türkiye: The number of people with susceptibility test result for rifampicin
Mexico
4,205
in 2021
Türkiye
3,654
in 2021
Mexico rank
34th
Türkiye rank
37th
The number of people with susceptibility test result for rifampicin over time
- Mexico
- Türkiye
How they compare
Mexico currently reports 4,205 against 3,654 in Türkiye, a difference of 551.
That makes Mexico's figure about 1.2 times Türkiye's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Türkiye ahead.
Mexico ranks 34th and Türkiye ranks 37th of 155 countries.
Türkiye has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mexico | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 183.67 | 4,810 | 4,626 | Türkiye |
| 2020s | 3,240 | 3,716 | 475.5 | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mexico or Türkiye?
- Mexico, at 4,205 against 3,654 in Türkiye as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mexico and Türkiye?
- 551, with Mexico ahead.
- How many years of comparable data are there for Mexico and Türkiye?
- 5 years are reported by both, from 2017 to 2021.
- How do Mexico and Türkiye rank globally for the number of people with susceptibility test result for rifampicin?
- Mexico ranks 34th and Türkiye ranks 37th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.